IKNA logo

Ikena Oncology (IKNA)

Profile

Full Name

Ikena Oncology, Inc.

Ticker Symbol

IKNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 26, 2021

Indexes

Not included

Website

http://ikenaoncology.com

Employees

10

Key Details

Price

$1.11(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.02(+37.42% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.11
IKNA price is $1.11

30-Day Relative Volume

1.62
IKNA 30-day relative volume is 1.62

Price Performance

Price Most recent change

0%
IKNA {parameterFullLabel} has remained unchanged on Apr 17, 2025

Price YTD change

-32.32%
IKNA price is down -32.32% since January 1st

Price 1-year change

-10.48%
IKNA price is down -10.48% year-on-year

Price 3-year change

-84.12%
IKNA price is down -84.12% over the past 3 years

Price Range

Price All-time high

$37.61
IKNA price is currently -97.05% below its historical high of $37.61

Price 3-year low

$0.97
IKNA price is currently +14.32% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$53.57M
IKNA market capitalization is $53.57 million

Market cap 3-year change

-77.73%
IKNA market capitalization is down -77.73% over the past 3 years

Market cap All-time high

$1.11B
IKNA market capitalization is currently -95.16% below its historical high of $1.11 billion

Market cap sector rank

39.09%
IKNA market capitalization is higher than 39.09% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
IKNA {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+40.23%
IKNA shares outstanding is up +40.23% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.37
IKNA beta is 0.37

200-day SMA

$1.57
IKNA price is currently -29.52% below its 200-day simple moving average

50-day SMA

$1.32
IKNA price is currently -15.81% below its 50-day simple moving average

RSI

38.70
IKNA 14-day relative strength index is 38.70

Volume

1.62
IKNA 30-day relative volume is 1.62

ATR

$0.09
IKNA average true range is $0.09

10-day Historical Volatility

77.80%
IKNA 10-day historical volatility is 77.80%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
IKNA annual revenue value is unknown

Revenue Analysts estimate

-
IKNA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
IKNA annual revenue 1-year change is unknown

Revenue Sector rank

-
IKNA annual revenue is unknown

EPS

EPS

-$1.02
IKNA annual earnings per share is -$1.02

EPS Analysts estimate

-$0.53
IKNA annual earnings per share is currently +92.45% higher than the consensus analysts' forecast

EPS 1-year change

+37.42%
IKNA annual earnings per share is up +37.42% year-on-year

EPS Sector rank

56.01%
IKNA annual earnings per share is higher than 56.01% of companies in Healthcare sector

Profit

Gross profit

-
IKNA annual gross profit value is unknown

Gross margin

-
IKNA annual gross profit margin value is unknown

Operating profit

-$54.55M
IKNA annual operating income is -$54.55 million

Operating margin

-
IKNA annual operating profit margin value is unknown

Net income

-$49.23M
IKNA annual net profit is -$49.23 million

Net margin

-
IKNA annual net profit margin value is unknown

Expenses

Total expenses

$54.55M
IKNA annual total expenses is $54.55 million

Operating expenses

$54.55M
IKNA annual total operating expenses is $54.55 million

Cost of goods sold

-
IKNA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$23.68M
IKNA annual SGA is $23.68 million

Depreciation and amortization

$490.00K
IKNA annual depreciation & amortization is $490.00 thousand

Interest expense

-
IKNA annual interest expense value is unknown

Income tax

$152.00K
IKNA annual income tax is $152.00 thousand

EBIT & EBITDA

EBIT

-$54.55M
IKNA annual earnings before interest & taxes is -$54.55 million

EBITDA

-$54.06M
IKNA annual EBITDA is -$54.06 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$141.51M
IKNA annual total assets is $141.51 million

Non current assets

$14.34M
IKNA annual long term assets is $14.34 million

Current assets

$127.17M
IKNA annual total current assets is $127.17 million

Cash and cash equivalents

$39.39M
IKNA annual cash & cash equivalents is $39.39 million

Accounts receivable

-
IKNA annual accounts receivable value is unknown

Inventory

-
IKNA annual inventory value is unknown

Liabilities

Total liabilities

$15.58M
IKNA annual total liabilities is $15.58 million

Long term liabilities

$4.80M
IKNA annual total long term liabilities is $4.80 million

Current liabilities

$10.78M
IKNA annual total current liabilities is $10.78 million

Accounts payable

$897.00K
IKNA annual accounts payable is $897.00 thousand

Debt

Total debt

$7.52M
IKNA annual total debt is $7.52 million

Total debt 1-year change

-29.96%
IKNA annual total debt is down -29.96% year-on-year

Long term debt

$3.74M
IKNA annual long term debt is $3.74 million

Short term debt

$3.78M
IKNA annual short term debt is $3.78 million

Equity & Capital

Shareholders equity

$125.93M
IKNA annual stockholders equity is $125.93 million

Book value

$125.93M
IKNA annual book value is $125.93 million

Retained earnings

-$331.62M
IKNA annual retained earnings is -$331.62 million

Working capital

$116.39M
IKNA annual working capital is $116.39 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$46.00M
IKNA annual cash flow from operations is -$46.00 million

Cash from operations 1-year change

+42.31%
IKNA annual cash flow from operations is up +42.31% year-on-year

Cash from investing

-$34.90M
IKNA annual cash flow from investing activities is -$34.90 million

Cash from investing 1-year change

-154.41%
IKNA annual cash flow from investing activities is down -154.41% year-on-year

Cash from financing

$0.00
IKNA annual cash flow from financing activities is $0.00

Cash from financing 1-year change

-100%
IKNA annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

-
IKNA annual capital expenditures value is unknown

CAPEX 1-year change

-
IKNA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$46.00M
IKNA annual free cash flow is -$46.00 million

Free cash flow 1-year change

+42.61%
IKNA annual free cash flow is up +42.61% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
IKNA annual gross profit margin value is unknown

Operating margin

-
IKNA annual operating profit margin value is unknown

Net margin

-
IKNA annual net profit margin value is unknown

ROA & ROE

ROA

-34.79%
IKNA annual return on assets is -34.79%

ROE

-39.10%
IKNA annual return on equity is -39.10%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IKNA price to earnings ratio value is unknown

PE ratio Sector rank

-
IKNA price to earnings ratio is unknown

PB Ratio

PB ratio

0.43
IKNA price to book ratio is 0.43

PB ratio Sector rank

27.54%
IKNA price to book ratio is higher than 27.54% of companies in Healthcare sector

PS Ratio

PS ratio

-
IKNA price to sales ratio value is unknown

PS ratio Sector rank

-
IKNA price to sales ratio is unknown

Enterprise value

Enterprise value

$21.69M
IKNA enterprise value is $21.69 million

Enterprise value Sector rank

32.48%
IKNA enterprise value is higher than 32.48% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.40
IKNA EV/EBITDA is -0.40

EV/EBITDA Sector rank

53.61%
IKNA EV/EBITDA is higher than 53.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

11.80
IKNA annual current ratio is 11.80

Quick ratio

-
IKNA annual quick ratio value is unknown

Leverage

Debt to equity

0.06
IKNA annual debt to equity ratio is 0.06

Interest coverage ratio

-
IKNA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
IKNA piotroski f-score value is unknown

Altman Z-Score

-
IKNA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 11, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
May 29, 24 Wedbush
Neutral
May 29, 24 HC Wainwright & Co.
Buy
May 14, 24 Wedbush
Outperform
Mar 19, 24 HC Wainwright & Co.
Buy
Mar 12, 24 HC Wainwright & Co.
Buy
Jan 19, 24 Wedbush
Outperform
Jan 19, 24 HC Wainwright & Co.
Buy
Nov 9, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

OWLT logo
Owlet (OWLT)
XCUR logo
Exicure (XCUR)
AKYA logo
Akoya Biosciences (AKYA)
KRON logo
Kronos Bio (KRON)
PMVP logo
PMV Pharmaceuticals (PMVP)
HYPR logo
Hyperfine (HYPR)
BYSI logo
BeyondSpring (BYSI)
SER logo
Serina Therapeutics (SER)
AGEN logo
Agenus (AGEN)
  • What is the ticker symbol for Ikena Oncology?
  • Does Ikena Oncology pay dividends?
  • What sector is Ikena Oncology in?
  • What industry is Ikena Oncology in?
  • What country is Ikena Oncology based in?
  • When did Ikena Oncology go public?
  • Is Ikena Oncology in the S&P 500?
  • Is Ikena Oncology in the NASDAQ 100?
  • Is Ikena Oncology in the Dow Jones?
  • When was Ikena Oncology's last earnings report?
  • When does Ikena Oncology report earnings?
  • Should I buy Ikena Oncology stock now?

What is the ticker symbol for Ikena Oncology?

The ticker symbol for Ikena Oncology is NASDAQ:IKNA

Does Ikena Oncology pay dividends?

No, Ikena Oncology does not pay dividends

What sector is Ikena Oncology in?

Ikena Oncology is in the Healthcare sector

What industry is Ikena Oncology in?

Ikena Oncology is in the Biotechnology industry

What country is Ikena Oncology based in?

Ikena Oncology is headquartered in United States

When did Ikena Oncology go public?

Ikena Oncology's initial public offering (IPO) was on March 26, 2021

Is Ikena Oncology in the S&P 500?

No, Ikena Oncology is not included in the S&P 500 index

Is Ikena Oncology in the NASDAQ 100?

No, Ikena Oncology is not included in the NASDAQ 100 index

Is Ikena Oncology in the Dow Jones?

No, Ikena Oncology is not included in the Dow Jones index

When was Ikena Oncology's last earnings report?

Ikena Oncology's most recent earnings report was on Nov 7, 2024

When does Ikena Oncology report earnings?

The next expected earnings date for Ikena Oncology is May 13, 2025

Should I buy Ikena Oncology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page